Tiffany Tolmie | Manager, Investor Relations |
Mark Murray | Chief Executive Officer |
Bruce Cousins | Chief Financial Officer |
Mike Sofia | Chief Scientific Officer |
Bill Symonds | Chief Development Officer |
Varun Kumar | Leerink Partners |
Audrey Le | William Blair |
Good day, ladies and gentlemen, and welcome to the Arbutus Biopharma Corporation Third Quarter 2017 Financial Results and Corporate Update. At this time all participants are in a listen only mode. Later we'll conduct a question-and-answer session and instruction will follow at that time. [Operator Instructions] As a reminder this conference is being recorded. I would now like to introduce your host for today's conference, Ms.